Your institution may have access to this item. Find your institution then sign in to continue.
Title
Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity.
Authors
Shafran, Ira; Burgunder, Patricia
Abstract
Enteric bacteria are thought to contribute to the pathogenesis of Crohn's disease, and antibiotics may be an effective therapy. This study examines the efficacy of the nonsystemic (<0.4% absorbed) antibiotic rifaximin for inducing remission in patients with Crohn's disease.
Publication
Digestive diseases and sciences, 2010, Vol 55, Issue 4, p1079